Free Trial

Marpai (MRAI) Competitors

Marpai logo
$1.34 +0.02 (+1.52%)
As of 08/8/2025 12:14 PM Eastern

MRAI vs. ATPC, BNR, BDSX, NAKA, PIII, KDLY, BMGL, CCM, BGLC, and BRTX

Should you be buying Marpai stock or one of its competitors? The main competitors of Marpai include Agape ATP (ATPC), Burning Rock Biotech (BNR), Biodesix (BDSX), KindlyMD (NAKA), P3 Health Partners (PIII), Kindly MD (KDLY), Basel Medical Group (BMGL), Concord Medical Services (CCM), BioNexus Gene Lab (BGLC), and Biorestorative Therapies (BRTX). These companies are all part of the "healthcare" industry.

Marpai vs. Its Competitors

Marpai (NASDAQ:MRAI) and Agape ATP (NASDAQ:ATPC) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, risk, profitability, institutional ownership, media sentiment, valuation, earnings and analyst recommendations.

In the previous week, Marpai had 1 more articles in the media than Agape ATP. MarketBeat recorded 2 mentions for Marpai and 1 mentions for Agape ATP. Marpai's average media sentiment score of 0.00 equaled Agape ATP'saverage media sentiment score.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Marpai
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Agape ATP
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Marpai has a net margin of -85.70% compared to Agape ATP's net margin of -191.34%. Marpai's return on equity of 0.00% beat Agape ATP's return on equity.

Company Net Margins Return on Equity Return on Assets
Marpai-85.70% N/A -100.23%
Agape ATP -191.34%-30.95%-27.00%

Agape ATP has lower revenue, but higher earnings than Marpai. Agape ATP is trading at a lower price-to-earnings ratio than Marpai, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Marpai$34.87M0.64-$28.75M-$1.82-0.74
Agape ATP$1.32M51.71-$2.47M-$0.60-2.28

49.8% of Marpai shares are owned by institutional investors. Comparatively, 0.0% of Agape ATP shares are owned by institutional investors. 46.1% of Marpai shares are owned by insiders. Comparatively, 9.7% of Agape ATP shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Marpai has a beta of 4.66, indicating that its stock price is 366% more volatile than the S&P 500. Comparatively, Agape ATP has a beta of -0.97, indicating that its stock price is 197% less volatile than the S&P 500.

Summary

Marpai beats Agape ATP on 8 of the 12 factors compared between the two stocks.

Get Marpai News Delivered to You Automatically

Sign up to receive the latest news and ratings for MRAI and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MRAI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MRAI vs. The Competition

MetricMarpaihealth & allied services, not elsewhere classified IndustryBusiness SectorNASDAQ Exchange
Market Cap$22.33M$183.19M$22.36B$9.72B
Dividend YieldN/AN/A2.84%4.12%
P/E Ratio-0.511.0528.1524.75
Price / Sales0.640.5441.2597.72
Price / CashN/A2.8027.1558.47
Price / Book-0.780.215.395.59
Net Income-$28.75M$43.11M$198.75M$265.99M
7 Day Performance13.56%64.61%12.01%5.07%
1 Month Performance-1.47%74.59%10.46%0.61%
1 Year Performance101.81%18.70%38.08%22.83%

Marpai Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MRAI
Marpai
N/A$1.34
+1.5%
N/A+101.8%$22.33M$34.87M-0.51150News Coverage
ATPC
Agape ATP
0.2967 of 5 stars
$1.41
+1.4%
N/A-44.7%$69.51M$1.32M-2.3540Upcoming Earnings
Gap Up
BNR
Burning Rock Biotech
0.8471 of 5 stars
$6.50
+5.6%
N/A+4.1%$66.21M$70.67M-3.441,390
BDSX
Biodesix
3.7085 of 5 stars
$0.42
+10.1%
$1.75
+313.7%
-74.8%$56.31M$71.32M-1.46220News Coverage
Earnings Report
Gap Down
NAKA
KindlyMD
N/A$7.24
-4.5%
N/AN/A$55.37M$2.72M-9.40N/AEarnings Report
PIII
P3 Health Partners
2.3204 of 5 stars
$6.92
-3.8%
$16.25
+135.0%
-78.5%$51.68M$1.50B-0.15500Upcoming Earnings
KDLY
Kindly MD
N/A$7.58
+19.4%
N/A+505.7%$45.65M$2.47M-9.84N/A
BMGL
Basel Medical Group
N/A$2.05
-0.5%
N/AN/A$38.02MN/A0.0036
CCM
Concord Medical Services
N/A$5.05
-5.4%
N/A-37.0%$23.18M$52.60M0.00970Positive News
Gap Down
BGLC
BioNexus Gene Lab
0.0812 of 5 stars
$5.73
-13.7%
N/A+29.1%$11.93M$9.51M0.0030Upcoming Earnings
BRTX
Biorestorative Therapies
3.1733 of 5 stars
$1.49
+0.7%
$18.00
+1,108.1%
+6.6%$11.11M$400K-1.017Upcoming Earnings

Related Companies and Tools


This page (NASDAQ:MRAI) was last updated on 8/10/2025 by MarketBeat.com Staff
From Our Partners